Mutual antagonism between IP3RII and miRNA-133a regulates calcium signals and 
cardiac hypertrophy

Drawnel, F. M.; Wachten, D.; Molkentin, J. D.; Maillet, M.; Aronsen, J. M.; Swift, F.; Sjaastad, I.; Liu, N.; Catalucci, D.; Mikoshiba, K.; Hisatsune, C.; Okkenhaug, H.; Andrews, S. R.; Bootman, M. D.; Roderick, H. L.

doi:DOI 10.1083/jcb.201111095

Item

ITEM ACTIONSEXPORT

Add to Basket

Local TagsRelease HistoryDetailsSummary

Released

Journal Article

Mutual antagonism between IP3RII and miRNA-133a regulates calcium signals and cardiac hypertrophy

MPS-Authors

/persons/resource/persons182737

Wachten, D.
Department of Molecular Sensory Systems, Center of Advanced European Studies and Research (caesar), Max Planck Society;

External Resource

http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3514786/pdf/JCB_201111095.pdf
(Any fulltext)

Fulltext (restricted access)

There are currently no full texts shared for your IP range.

Fulltext (public)

There are no public fulltexts stored in PuRe

Supplementary Material (public)

There is no public supplementary material available

Citation

Drawnel, F. M., Wachten, D., Molkentin, J. D., Maillet, M., Aronsen, J. M., Swift, F., et al. (2012). Mutual antagonism between IP3RII and miRNA-133a regulates calcium signals and cardiac hypertrophy. Journal of Cell Biology, 199(5), 783-798. doi:DOI 10.1083/jcb.201111095.

Cite as: https://hdl.handle.net/11858/00-001M-0000-0028-61DF-3

Abstract

Inositol 1,4,5'-triphosphate receptor II (IP3RII) calcium channel expression is increased in both hypertrophic failing human myocardium and experimentally induced models of the disease. The ectopic calcium released from these receptors induces pro-hypertrophic gene expression and may promote arrhythmias. Here, we show that IP3RII expression was constitutively restrained by the muscle-specific miRNA, miR-133a. During the hypertrophic response to pressure overload or neurohormonal stimuli, miR-133a down-regulation permitted IP3RII levels to increase, instigating pro-hypertrophic calcium signaling and concomitant pathological remodeling. Using a combination of in vivo and in vitro approaches, we demonstrated that IP3-induced calcium release (IICR) initiated the hypertrophy-associated decrease in miR-133a. In this manner, hypertrophic stimuli that engage IICR set a feedforward mechanism in motion whereby IICR decreased miR-133a expression, further augmenting IP3RII levels and therefore pro-hypertrophic calcium release. Consequently, IICR can be considered as both an initiating event and a driving force for pathological remodeling.